{"id":843476,"date":"2025-04-29T10:33:00","date_gmt":"2025-04-29T14:33:00","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\/"},"modified":"2025-04-29T10:33:00","modified_gmt":"2025-04-29T14:33:00","slug":"myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\/","title":{"rendered":"Myriad Genetics to Release First Quarter 2025 Financial Results\u00a0on May 6, 2025"},"content":{"rendered":"<h2>\nManagement will participate in two upcoming investor healthcare conferences<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"left\">SALT LAKE CITY, April  29, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Xu6yKx7DxYPKXMRLe3UDRvPVnGTXJeQw62vy_jEE-cQ3f6HEz4phePDh4BaOjkz5uaO17HmRN820332KFf_KKMZhrCGLYacxeez0Vwk5KcM=\" rel=\"nofollow\" target=\"_blank\">Myriad Genetics, Inc<\/a>. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine,\u00a0will hold its first quarter 2025 earnings conference call at 4:30 pm EDT on Tuesday, May 6, 2025. The company\u2019s quarterly earnings will be released the same day after the market closes. During the call, Myriad management will provide a financial overview and business update of the company\u2019s performance for the first quarter 2025.<\/p>\n<p>A live webcast of the conference call can be accessed on Myriad\u2019s Investor Relations website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=X9gp8cih3As487YHLAtyuomZcL7tHnRQLMl_cCetxUOAhbwH4PsP59wgRktbv8aQVpgpWG1K80fKTfVYcO3hSXmddYEZsDRatRsd7YpyAS8=\" rel=\"nofollow\" target=\"_blank\">investor.myriad.com<\/a>. To participate in the live conference call via telephone, please register <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fIWoD7Zec5KC32CtmxgeiD8uCpi06whxkNTFlvGQbEx86FvN1zPKRXj38w_cHBrumJVai14uF0uDJ42c1kxHMCTzrA_Zzm1k7ncgX65sZBxGtKZb4SlmKm6hZZqhAZ5Vnd5YcCWqrBIz9A6b5YPVLC0H6lcr8gJeYAecFTOQKvw=\" rel=\"nofollow\" target=\"_blank\">here<\/a>. Upon registering, a dial-in number and unique PIN will be provided to join the conference call. An archived webcast of the call will be available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=X9gp8cih3As487YHLAtyuhscMB-HjE44brugBlMgMNX4afV7QbgMLx0EY0AeinkGyFdilopzmD-VVcZCjuGw1EoCHVfRfTAUXTCoZqcoopQ=\" rel=\"nofollow\" target=\"_blank\">investor.myriad.com<\/a> following the call.<\/p>\n<p>\n        <strong>Upcoming Q2 Investor Conferences<\/strong><br \/>\n        <br \/>Management plans to participate in the following investor healthcare conferences:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>The BofA Securities 2025 Health Care Conference<\/strong> \u2013 fireside chat at 3:00 pm EDT on Wednesday, May 14, 2025.<\/li>\n<li>\n          <strong>Goldman Sachs 46<\/strong><br \/>\n          <sup><br \/>\n            <strong>th<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual Global Healthcare Conference<\/strong> \u2013 fireside chat at 2:00 pm EDT on Wednesday, June 11, 2025.<\/li>\n<\/ul>\n<p>Live and archived webcasts of all presentations can be viewed at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=X9gp8cih3As487YHLAtyupa35rTknW6hGZQhGlJlmSCmNFAyTh9VVcaBU9Rv4rvin0Lxqf-kRWOX3RtsqUakLMV4PBUq2pwpJrWVytHZax4=\" rel=\"nofollow\" target=\"_blank\">investor.myriad.com<\/a>.<\/p>\n<p>\n        <strong>About Myriad Genetics<\/strong><br \/>\n        <br \/>Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and offers molecular tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care and lower healthcare costs. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HmGWvq11VmvrvqoUH4WxZL9-vsx08ugIkAnF5rGxbCBVmBCnezgkOeqO-zfVb92nzMNyIRGS_ohFD8pt6l4OfQ==\" rel=\"nofollow\" target=\"_blank\">www.myriad.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact\u00a0<\/strong><br \/>\n        <br \/>Matt Scalo\u00a0<br \/>(801) 584-3532\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=B3gjusurKxfsI5wr5FI2SsolT_LlaWUQDJmBLUqMv9M7MzzCAYhK8S2RtQ-1Q7VPSGC68DcAq-QGY22DxtAJ2Q==\" rel=\"nofollow\" target=\"_blank\"><u>IR@myriad.com<\/u><\/a>\u00a0<\/p>\n<p>\n        <strong>Media Contact\u00a0<\/strong><br \/>\n        <br \/>Kate Schraml<br \/>(224) 875-4493<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wT7OBA2yKSKgMOTQKZK5Pkh4gYN1NxhqrxuvwZX8ZfKS6zUJ23ZolvAXZwEiqsnQZEIDPyaBaXM3B6X__QvcbQ==\" rel=\"nofollow\" target=\"_blank\"><u>PR@myriad.com<\/u><\/a>\u00a0\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0MDMwNiM2OTA4NDk5IzIwMDc4ODc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OTQ3ZDMwYzItYWZkNi00MjJjLWI1NzktMTg3Y2Y3YTQ2OWI2LTEwMTk0NjAtMjAyNS0wNC0yOS1lbg==\/tiny\/Myriad-Genetics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Management will participate in two upcoming investor healthcare conferences SALT LAKE CITY, April 29, 2025 (GLOBE NEWSWIRE) &#8212; Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine,\u00a0will hold its first quarter 2025 earnings conference call at 4:30 pm EDT on Tuesday, May 6, 2025. The company\u2019s quarterly earnings will be released the same day after the market closes. During the call, Myriad management will provide a financial overview and business update of the company\u2019s performance for the first quarter 2025. A live webcast of the conference call can be accessed on Myriad\u2019s Investor Relations website at investor.myriad.com. To participate in the live conference call via telephone, please register here. Upon registering, a dial-in number and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Myriad Genetics to Release First Quarter 2025 Financial Results\u00a0on May 6, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-843476","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Myriad Genetics to Release First Quarter 2025 Financial Results\u00a0on May 6, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Myriad Genetics to Release First Quarter 2025 Financial Results\u00a0on May 6, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Management will participate in two upcoming investor healthcare conferences SALT LAKE CITY, April 29, 2025 (GLOBE NEWSWIRE) &#8212; Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine,\u00a0will hold its first quarter 2025 earnings conference call at 4:30 pm EDT on Tuesday, May 6, 2025. The company\u2019s quarterly earnings will be released the same day after the market closes. During the call, Myriad management will provide a financial overview and business update of the company\u2019s performance for the first quarter 2025. A live webcast of the conference call can be accessed on Myriad\u2019s Investor Relations website at investor.myriad.com. To participate in the live conference call via telephone, please register here. Upon registering, a dial-in number and &hellip; Continue reading &quot;Myriad Genetics to Release First Quarter 2025 Financial Results\u00a0on May 6, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-29T14:33:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0MDMwNiM2OTA4NDk5IzIwMDc4ODc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Myriad Genetics to Release First Quarter 2025 Financial Results\u00a0on May 6, 2025\",\"datePublished\":\"2025-04-29T14:33:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\\\/\"},\"wordCount\":295,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0MDMwNiM2OTA4NDk5IzIwMDc4ODc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\\\/\",\"name\":\"Myriad Genetics to Release First Quarter 2025 Financial Results\u00a0on May 6, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0MDMwNiM2OTA4NDk5IzIwMDc4ODc=\",\"datePublished\":\"2025-04-29T14:33:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0MDMwNiM2OTA4NDk5IzIwMDc4ODc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0MDMwNiM2OTA4NDk5IzIwMDc4ODc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Myriad Genetics to Release First Quarter 2025 Financial Results\u00a0on May 6, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Myriad Genetics to Release First Quarter 2025 Financial Results\u00a0on May 6, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\/","og_locale":"en_US","og_type":"article","og_title":"Myriad Genetics to Release First Quarter 2025 Financial Results\u00a0on May 6, 2025 - Market Newsdesk","og_description":"Management will participate in two upcoming investor healthcare conferences SALT LAKE CITY, April 29, 2025 (GLOBE NEWSWIRE) &#8212; Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine,\u00a0will hold its first quarter 2025 earnings conference call at 4:30 pm EDT on Tuesday, May 6, 2025. The company\u2019s quarterly earnings will be released the same day after the market closes. During the call, Myriad management will provide a financial overview and business update of the company\u2019s performance for the first quarter 2025. A live webcast of the conference call can be accessed on Myriad\u2019s Investor Relations website at investor.myriad.com. To participate in the live conference call via telephone, please register here. Upon registering, a dial-in number and &hellip; Continue reading \"Myriad Genetics to Release First Quarter 2025 Financial Results\u00a0on May 6, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-29T14:33:00+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0MDMwNiM2OTA4NDk5IzIwMDc4ODc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Myriad Genetics to Release First Quarter 2025 Financial Results\u00a0on May 6, 2025","datePublished":"2025-04-29T14:33:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\/"},"wordCount":295,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0MDMwNiM2OTA4NDk5IzIwMDc4ODc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\/","name":"Myriad Genetics to Release First Quarter 2025 Financial Results\u00a0on May 6, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0MDMwNiM2OTA4NDk5IzIwMDc4ODc=","datePublished":"2025-04-29T14:33:00+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0MDMwNiM2OTA4NDk5IzIwMDc4ODc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0MDMwNiM2OTA4NDk5IzIwMDc4ODc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-release-first-quarter-2025-financial-results-on-may-6-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Myriad Genetics to Release First Quarter 2025 Financial Results\u00a0on May 6, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/843476","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=843476"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/843476\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=843476"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=843476"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=843476"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}